Prospective follow-up of clinical efficacy of knee distraction as treatment for knee OA by use of 'ArthroSave's Knee-Reviver'.

Prospective follow-up of clinical efficacy of knee distraction as treatment for knee OA by use of 'ArthroSave's Knee-Reviver'. - Prospective follow-up of 'ArthroSave's Knee-Reviver'.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55548

Enrollment

Registered

2017-07-03

Start date

2017-11-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - adults 40/100 (conservative treatment resistant)

Exclusion criteria

Exclusion criteria: General: Patients that would not be considered for arthroplasty or osteotomy because of psychosocial condition; or who meet any of the following criteria will be excluded from participation in this study: - Comorbidities that would compromise the efficacy of knee joint distraction (arbitrary defined by orthopaedic surgeons) - History of inflammatory or septic arthritis - Knee mal-alignment of more than 10 degrees - Previous surgical interventions of the index knee

Design outcomes

Primary

Measure	Time frame
WOMAC score (pre-treatment vs. follow-up) radiographic joint space width (pre-treatment vs. follow-up)	—

Secondary

Measure	Time frame
To document changes in general well-being after Knee Joint Distraction, using ArthroSave*s Knee-Reviver (using SF-36 questionnaire) To document clinical efficacy/ patient satisfaction of subsequent surgical procedures after KJD	—

Countries

Netherlands

Outcome results